C17orf67
gene geneOn this page
Summary
C17orf67 (chromosome 17 open reading frame 67, HGNC:27900) is a protein-coding gene on chromosome 17q22, encoding Uncharacterized protein C17orf67 (Q0P5P2).
Predicted to be located in extracellular region.
Source: NCBI Gene 339210 — RefSeq curated summary.
At a glance
- GWAS associations: 13
- Clinical variants (ClinVar): 7 total
- MANE Select transcript:
NM_001085430
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:27900 |
| Approved symbol | C17orf67 |
| Name | chromosome 17 open reading frame 67 |
| Location | 17q22 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000214226 |
| Ensembl biotype | protein_coding |
| Entrez | 339210 |
Gene structure
Transcript identifiers
Ensembl transcripts: 22 — 20 protein_coding, 1 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000397861, ENST00000487705, ENST00000570754, ENST00000870326, ENST00000870327, ENST00000870328, ENST00000870329, ENST00000870330, ENST00000870331, ENST00000870332, ENST00000870333, ENST00000870334, ENST00000870335, ENST00000870336, ENST00000870337, ENST00000870338, ENST00000870339, ENST00000870340, ENST00000870341, ENST00000939699, ENST00000971316, ENST00000971317
RefSeq mRNA: 1 — MANE Select: NM_001085430
NM_001085430
CCDS: CCDS42364
Canonical transcript exons
ENST00000397861 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001530502 | 56833618 | 56833920 |
| ENSE00001530504 | 56795044 | 56795180 |
| ENSE00001530505 | 56814869 | 56814969 |
| ENSE00001530507 | 56815756 | 56816010 |
| ENSE00001530509 | 56824739 | 56824853 |
| ENSE00001530510 | 56825081 | 56825321 |
| ENSE00001530512 | 56832898 | 56833342 |
| ENSE00001929077 | 56791913 | 56792352 |
Expression profiles
Bgee: expression breadth ubiquitous, 169 present calls, max score 85.31.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 4.3744 / max 49.1111, expressed in 1616 samples.
FANTOM5 promoters (8 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 167109 | 2.8396 | 1345 |
| 167110 | 1.4023 | 862 |
| 167108 | 0.0844 | 28 |
| 167105 | 0.0132 | 5 |
| 167104 | 0.0120 | 3 |
| 167106 | 0.0102 | 5 |
| 167098 | 0.0092 | 5 |
| 167107 | 0.0035 | 2 |
Top tissues by expression
241 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.31 | gold quality |
| kidney epithelium | UBERON:0004819 | 84.77 | gold quality |
| upper arm skin | UBERON:0004263 | 83.06 | gold quality |
| pancreatic ductal cell | CL:0002079 | 82.88 | silver quality |
| gingival epithelium | UBERON:0001949 | 82.73 | gold quality |
| thymus | UBERON:0002370 | 80.54 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 79.73 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 79.00 | gold quality |
| gingiva | UBERON:0001828 | 78.40 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 76.83 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 76.45 | gold quality |
| superficial temporal artery | UBERON:0001614 | 76.19 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 76.13 | gold quality |
| cardia of stomach | UBERON:0001162 | 75.43 | silver quality |
| vena cava | UBERON:0004087 | 75.28 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 75.26 | gold quality |
| cerebellar vermis | UBERON:0004720 | 75.24 | gold quality |
| pons | UBERON:0000988 | 75.08 | gold quality |
| tibialis anterior | UBERON:0001385 | 74.78 | silver quality |
| lateral globus pallidus | UBERON:0002476 | 74.63 | gold quality |
| dorsal plus ventral thalamus | UBERON:0001897 | 74.43 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 74.40 | gold quality |
| right lobe of liver | UBERON:0001114 | 74.34 | gold quality |
| trachea | UBERON:0003126 | 74.28 | gold quality |
| body of tongue | UBERON:0011876 | 74.26 | gold quality |
| pericardium | UBERON:0002407 | 74.24 | gold quality |
| tongue | UBERON:0001723 | 74.13 | gold quality |
| nipple | UBERON:0002030 | 74.07 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 74.04 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 73.99 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-6701 | yes | 14.92 |
| E-ANND-3 | no | 2.75 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
26 targeting C17orf67, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-4776-3P | 100.00 | 68.73 | 1340 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-4267 | 99.96 | 66.53 | 2368 |
| HSA-MIR-544A | 99.84 | 68.66 | 1965 |
| HSA-MIR-3156-3P | 99.76 | 66.72 | 939 |
| HSA-MIR-5004-5P | 99.68 | 66.63 | 1294 |
| HSA-MIR-657 | 99.48 | 66.02 | 848 |
| HSA-MIR-3125 | 99.14 | 68.49 | 2269 |
| HSA-MIR-3916 | 98.99 | 68.04 | 2155 |
| HSA-MIR-6859-5P | 98.99 | 68.07 | 2049 |
| HSA-MIR-5197-3P | 98.71 | 67.05 | 1905 |
| HSA-MIR-4436B-3P | 98.25 | 65.26 | 1494 |
| HSA-MIR-6735-5P | 98.24 | 65.36 | 1488 |
| HSA-MIR-7843-5P | 98.12 | 65.26 | 1421 |
| HSA-MIR-4632-5P | 97.82 | 65.38 | 1470 |
| HSA-MIR-6879-5P | 97.77 | 65.52 | 1521 |
| HSA-MIR-4714-5P | 97.04 | 67.76 | 955 |
| HSA-MIR-2909 | 96.36 | 67.30 | 562 |
| HSA-MIR-1245A | 96.33 | 66.25 | 498 |
| HSA-MIR-8079 | 96.33 | 66.11 | 484 |
| HSA-MIR-5586-5P | 96.29 | 68.02 | 685 |
| HSA-MIR-4761-3P | 96.27 | 66.26 | 524 |
| HSA-MIR-431-5P | 96.16 | 66.50 | 652 |
| HSA-MIR-4737 | 89.94 | 65.03 | 82 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | si:dkey-31g6.6 | ENSDARG00000101393 |
| mus_musculus | Gm525 | ENSMUSG00000072553 |
| rattus_norvegicus | C10h17orf67 | ENSRNOG00000064206 |
Protein
Protein identifiers
Uncharacterized protein C17orf67 — Q0P5P2 (reviewed: Q0P5P2)
All UniProt accessions (1): Q0P5P2
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Secreted.
RefSeq proteins (1): NP_001078899* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR027870 | DUF4543 | Family |
Pfam: PF15076
UniProt features (3 total): signal peptide 1, chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q0P5P2-F1 | 76.76 | 0.15 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 36 (showing top):
NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON, chr17q22, LI_INDUCED_T_TO_NATURAL_KILLER_DN, DLX2_TARGET_GENES, NAB2_TARGET_GENES, ZNF146_TARGET_GENES, ZNF711_TARGET_GENES, ZSCAN30_TARGET_GENES, MIR3125, MIR3916, MIR6859_5P, MIR544A, MIR4436B_3P, MIR6879_5P, MIR6735_5P
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): extracellular region (GO:0005576)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
294 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| C17orf67 | BSPH1 | Q075Z2 | 572 |
| C17orf67 | ANKFN1 | Q8N957 | 560 |
| C17orf67 | DGKE | P52429 | 538 |
| C17orf67 | RUFY1 | Q96T51 | 490 |
| C17orf67 | RFLNA | Q6ZTI6 | 462 |
| C17orf67 | DOT1L | Q8TEK3 | 461 |
| C17orf67 | ILRUN | Q9H6K1 | 446 |
| C17orf67 | ANKAR | Q7Z5J8 | 446 |
| C17orf67 | FAM180A | Q6UWF9 | 437 |
| C17orf67 | SYNGR2 | O43760 | 435 |
| C17orf67 | BNC2 | Q6ZN30 | 430 |
| C17orf67 | POC5 | Q8NA72 | 423 |
| C17orf67 | SCPEP1 | Q9HB40 | 414 |
| C17orf67 | PINLYP | A6NC86 | 394 |
| C17orf67 | HSPG2 | P98160 | 389 |
IntAct
10 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| C17orf67 | CADPS | psi-mi:“MI:0915”(physical association) | 0.560 |
| GOPC | C17orf67 | psi-mi:“MI:0915”(physical association) | 0.560 |
| C17orf67 | GOPC | psi-mi:“MI:0915”(physical association) | 0.560 |
| C17orf67 | OPTN | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (2): C17orf67 (Two-hybrid), C17orf67 (Two-hybrid)
ESM2 similar proteins: A0A0K8RAI0, A0A0K8RCU3, A0A0K8RDJ1, A0A141SFN4, A0A158RFT4, A0A1D0BN92, B4G532, B4R1P9, C0HKG1, D3JWK7, E2J6T4, E9Q7F5, F5HB98, F5HHQ0, O08546, O36359, P01587, P04671, P08864, P0CD95, P0CE75, P0CE76, P0DPY3, P0DPY9, P0DQE5, P0DQV0, P11450, P25140, P28907, P28981, P33496, P34468, P54356, P68326, P68329, P86899, P89679, Q00997, Q0P5P2, Q17RF5
Diamond homologs: P0CD95, Q0P5P2, Q3V3I5
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
7 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 1 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1630 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:56797779:T:TA | donor_gain | 0.9900 |
| 17:56827323:CTG:C | donor_gain | 0.9900 |
| 17:56834257:CGAG:C | donor_loss | 0.9900 |
| 17:56834259:AG:A | donor_loss | 0.9900 |
| 17:56834260:GGTA:G | donor_loss | 0.9900 |
| 17:56834312:GGGC:G | donor_gain | 0.9900 |
| 17:56835203:T:G | donor_gain | 0.9900 |
| 17:56835214:TTTGC:T | donor_gain | 0.9900 |
| 17:56792353:C:CC | acceptor_gain | 0.9800 |
| 17:56799903:T:C | acceptor_gain | 0.9800 |
| 17:56815037:C:CT | acceptor_gain | 0.9800 |
| 17:56834773:GTTA:G | acceptor_loss | 0.9800 |
| 17:56834775:TA:T | acceptor_loss | 0.9800 |
| 17:56834776:A:AT | acceptor_loss | 0.9800 |
| 17:56835255:TACAG:T | donor_loss | 0.9800 |
| 17:56835256:ACAG:A | donor_loss | 0.9800 |
| 17:56835257:CAGG:C | donor_loss | 0.9800 |
| 17:56835258:AGGTA:A | donor_loss | 0.9800 |
| 17:56835259:GG:G | donor_loss | 0.9800 |
| 17:56835260:G:GA | donor_loss | 0.9800 |
| 17:56835261:T:C | donor_loss | 0.9800 |
| 17:56834771:T:TA | acceptor_gain | 0.9700 |
| 17:56834772:G:A | acceptor_gain | 0.9700 |
| 17:56835123:GAGAT:G | donor_gain | 0.9700 |
| 17:56795181:C:CC | acceptor_gain | 0.9600 |
| 17:56799903:T:TC | acceptor_gain | 0.9600 |
| 17:56815038:A:T | acceptor_gain | 0.9600 |
| 17:56816524:TTACA:T | acceptor_gain | 0.9600 |
| 17:56827322:A:AC | donor_gain | 0.9600 |
| 17:56827323:C:CC | donor_gain | 0.9600 |
AlphaMissense
581 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:56814887:G:C | F46L | 0.971 |
| 17:56814887:G:T | F46L | 0.971 |
| 17:56814889:A:G | F46L | 0.971 |
| 17:56795118:C:A | W73C | 0.949 |
| 17:56795118:C:G | W73C | 0.949 |
| 17:56795112:G:C | N75K | 0.948 |
| 17:56795112:G:T | N75K | 0.948 |
| 17:56795104:C:G | C78S | 0.945 |
| 17:56795105:A:T | C78S | 0.945 |
| 17:56814896:T:A | K43N | 0.942 |
| 17:56814896:T:G | K43N | 0.942 |
| 17:56795092:C:G | C82S | 0.941 |
| 17:56795093:A:T | C82S | 0.941 |
| 17:56795164:A:G | L58P | 0.941 |
| 17:56814940:C:G | A29P | 0.941 |
| 17:56795104:C:T | C78Y | 0.940 |
| 17:56814923:T:A | R34S | 0.938 |
| 17:56814923:T:G | R34S | 0.938 |
| 17:56795103:G:C | C78W | 0.935 |
| 17:56795092:C:T | C82Y | 0.930 |
| 17:56814930:A:G | L32P | 0.926 |
| 17:56795091:A:C | C82W | 0.925 |
| 17:56795105:A:G | C78R | 0.921 |
| 17:56795116:A:G | L74P | 0.919 |
| 17:56795093:A:G | C82R | 0.910 |
| 17:56795104:C:A | C78F | 0.910 |
| 17:56795152:T:A | E62V | 0.909 |
| 17:56795120:A:G | W73R | 0.907 |
| 17:56795120:A:T | W73R | 0.907 |
| 17:56814924:C:G | R34T | 0.906 |
dbSNP variants (sampled 300 via entrez): RS1000030102 (17:56792026 A>G), RS1000037684 (17:56807638 T>C), RS1000051377 (17:56807042 G>A), RS1000073733 (17:56833662 TC>T,TCC), RS1000125769 (17:56818221 T>C), RS1000203214 (17:56832136 C>T), RS1000257081 (17:56828582 T>C), RS1000286577 (17:56828291 G>T), RS1000349824 (17:56797832 G>A), RS1000365471 (17:56820459 C>T), RS1000393002 (17:56820634 C>T), RS1000501656 (17:56809408 G>A,T), RS1000510378 (17:56833497 G>A), RS1000598161 (17:56816248 A>G), RS1000744945 (17:56826287 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
13 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002647_151 | Height | 1.000000e-23 |
| GCST002702_2 | Height | 6.000000e-06 |
| GCST004132_96 | Crohn’s disease | 4.000000e-06 |
| GCST004166_28 | Nonsyndromic cleft lip with cleft palate | 9.000000e-09 |
| GCST005537_34 | Chronic inflammatory diseases (ankylosing spondylitis, Crohn’s disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy) | 2.000000e-08 |
| GCST006291_37 | Spherical equivalent or myopia (age of diagnosis) | 2.000000e-12 |
| GCST008058_256 | Estimated glomerular filtration rate | 7.000000e-13 |
| GCST008178_13 | Early spontaneous preterm birth | 8.000000e-06 |
| GCST008839_301 | Height | 4.000000e-17 |
| GCST010988_64 | Adult body size | 4.000000e-08 |
| GCST012226_800 | Waist circumference adjusted for body mass index | 1.000000e-10 |
| GCST012226_801 | Waist circumference adjusted for body mass index | 4.000000e-08 |
| GCST012227_343 | Hip circumference adjusted for BMI | 5.000000e-11 |
EFO canonical traits (5, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0003959 | cleft lip |
| EFO:0004847 | age at onset |
| EFO:0006917 | spontaneous preterm birth |
| EFO:0007789 | BMI-adjusted waist circumference |
| EFO:0008039 | BMI-adjusted hip circumference |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
18 total (human), top 18 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Air Pollutants | affects expression, increases abundance, decreases expression | 2 |
| Tobacco Smoke Pollution | increases expression | 2 |
| butyraldehyde | decreases expression | 1 |
| PCI 5002 | affects cotreatment, increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Arsenic | affects methylation | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Drugs, Chinese Herbal | increases expression | 1 |
| Methotrexate | decreases expression | 1 |
| Naphthoquinones | increases expression | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Zinc | increases expression, affects cotreatment | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Acrylamide | increases expression | 1 |
| Permethrin | decreases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.